ストックスクリーナーアプリを入手
0.3545
0.91%
-0.0012
前日終値:
$0.3533
開ける：
$0.3575
24時間の取引高:
999.17K
Relative Volume:
0.92
時価総額：
$11.58M
収益：
$950.10K
当期純損益:
$-16.69M
株価収益率:
-0.4271
EPS:
-0.83
ネットキャッシュフロー:
$-15.16M
1週間 パフォーマンス:
-2.70%
1か月 パフォーマンス:
-32.03%
6か月 パフォーマンス:
-78.12%
1年 パフォーマンス:
-69.02%
1日の値動き範囲:
$0.3466
$0.3575
1週間の範囲:
$0.3423
$0.37
52週間の値動き範囲:
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
FEMY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.3556 | 11.22M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
437.45 | 160.51B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
179.06 | 53.46B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
265.11 | 40.35B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
73.92 | 37.18B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
253.53 | 18.03B | 2.96B | 487.70M | 344.00M | 6.68 |
Femasys Inc (FEMY) 最新ニュース
Femasys Inc. Partners with Kebomed to Expand FemBloc Permanent Birth Control Availability in France and Benelux Region - Quiver Quantitative
Femasys announces partnership with Kebomend to commercialize FemBloc - TipRanks
First Non-Surgical Permanent Birth Control: Femasys' FemBloc Launches Major European Expansion - Stock Titan
Femasys partners with Medical Electronic Systems for FemSperm kit - Yahoo Finance
Femasys partners with MES to launch sperm analysis kit By Investing.com - Investing.com Nigeria
Comparing Femasys Inc. in custom built stock radarsMarket Growth Summary & Real-Time Sentiment Analysis - newser.com
Technical signs of recovery in Femasys Inc.July 2025 Review & Risk Controlled Swing Trade Alerts - newser.com
Femasys partners with MES to launch sperm analysis kit - Investing.com India
How to track smart money flows in Femasys Inc.2025 Market Outlook & Growth Focused Investment Plans - newser.com
Femasys Inc. recovery potential after sell offEarnings Risk Report & Daily Oversold Stock Bounce Ideas - newser.com
Femasys Inc. Partners with Medical Electronic Systems to Launch FemSperm Analysis Kit, Enhancing In-Office Infertility Treatment - Quiver Quantitative
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed - GlobeNewswire
2X Higher Pregnancy Rates: Femasys Expands FemSperm Line for Revolutionary FemaSeed Fertility Treatment - Stock Titan
Critical Comparison: PDS Biotechnology (NASDAQ:PDSB) and Femasys (NASDAQ:FEMY) - Defense World
Market Pulse: Is Femasys Inc stock undervalued right nowEarnings Recap Summary & Daily Profit Focused Stock Screening - خودرو بانک
Setup Watch: Will Femasys Inc. benefit from current market trendsQuarterly Trade Report & Technical Confirmation Trade Alerts - خودرو بانک
Using flow based indicators on Femasys Inc.Earnings Summary Report & Community Driven Trade Alerts - newser.com
What MACD and RSI say about Femasys Inc.Earnings Trend Report & Real-Time Buy Signal Alerts - newser.com
Short interest data insights for Femasys Inc.Weekly Profit Analysis & Technical Confirmation Alerts - newser.com
Buy Signal: Can ARCT stock double in the next yearJuly 2025 Trade Ideas & Step-by-Step Swing Trade Plans - khodrobank.com
Market Outlook: Is Femasys Inc. a turnaround storyQuarterly Trade Review & Precise Entry and Exit Recommendations - khodrobank.com
Key metrics from Femasys Inc.’s quarterly dataMarket Performance Recap & Stock Portfolio Risk Management - newser.com
Is Femasys Inc benefiting from interest rate changesQuarterly Profit Review & Low Risk High Win Rate Picks - خودرو بانک
Femasys Inc. stock trend outlook and recovery path2025 Sector Review & Low Risk High Win Rate Picks - newser.com
Can trapped investors hope for a rebound in Femasys Inc.Forecast Cut & Safe Capital Allocation Plans - newser.com
Options Flow: Is Femasys Inc stock undervalued right nowJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - خودرو بانک
Detecting support and resistance levels for Femasys Inc.Portfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com
Femasys stock falls after pricing capital raise of $8M via securities offering - MSN
Volatility Watch: Is Femasys Inc a momentum stockJobs Report & Capital Efficient Trade Techniques - خودرو بانک
How institutional ownership impacts Femasys Inc. stockEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
Aug Setups: Can Femasys Inc. deliver consistent dividendsWeekly Profit Recap & Free Growth Oriented Trading Recommendations - khodrobank.com
Stock Market Recap: Is Femasys Inc. a potential multi baggerWeekly Investment Summary & Short-Term High Return Strategies - khodrobank.com
Will Femasys Inc. price bounce be sustainablePortfolio Growth Summary & High Conviction Buy Zone Picks - newser.com
Chart based exit strategy for Femasys Inc.2025 AllTime Highs & High Conviction Trade Alerts - newser.com
Femasys Attracts $8 Million in Funding - Medical Product Outsourcing
Femasys Inc. Expands FemSperm?? Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemSeed - MarketScreener
Femasys Inc. Launches FemSperm Insemination Prep Kit to Enhance Accessibility of Fertility Treatments - Quiver Quantitative
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed® - The Manila Times
Femasys expands FemSperm product line with Insemination Prep Kit - TipRanks
10M Women Could Benefit: Femasys Launches Game-Changing Fertility Kit for Gynecologist Offices - Stock Titan
Femasys Expands FemSperm™ Product Line with New - GlobeNewswire
Femasys Gains UK Approval for FemBloc Birth Control - MSN
Merger Talk: Is Femasys Inc. a turnaround storyJuly 2025 Fed Impact & Stock Market Timing Techniques - 뉴스영
Femasys Inc. Receives MEDSAFE Approval for FemBloc Permanent Birth Control in New Zealand, Expanding Global Access to Innovative Women's Health Solutions - Quiver Quantitative
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand - GlobeNewswire
Femasys Inc (FEMY) 財務データ
収益
当期純利益
現金流量
EPS
2.77%
大文字化:
|
ボリューム (24 時間):